WithdrawnNo phase
Data Collection Registry of the HeRO Graft for End Stage Renal Disease Patients Receiving Hemodialysis
Key facts
- Who runs it
- Merit Medical Systems, Inc.
- Where
- Dallas, Durham, and Norfolk, United StatesSee the 3 sites
- Trial code
- Status
- Withdrawn
- Started
- Dec 2013
- Ended
- Dec 2023
- Type of study
- Observational
- Treatments tested
- HeRO Graft implant for dialysis access
- Record updated
- 10 May 2021
- Why it stopped
- Company acquired and trial was not pursued
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- All patients eligible for HeRO Graft for dialysis access
- Age greater than 18 years old
- Able to give informed consent
Who cannot take part
- Subjects with any kind of disorder that compromises the ability of the subject to give informed consent and/or to comply with the study procedures
- Any medical condition that in the opinion of the investigator may pose a safety risk to a subject in the study or which may interfere with study participation
Where in United States
- Baylor Research InstituteDallas, United StatesNo longer taking part
- Duke University Medical CenterDurham, United StatesNo longer taking part
- Sentara Medical Group Sentara Vascular SpecialistsNorfolk, United StatesNo longer taking part
About the trial
What the trial wants to find out
Data Collection Registry of the HeRO Graft for End Stage Renal Disease Patients Receiving Hemodialysis
The group in the trial
- HeRO Graft
End stage renal disease patients who receive HeRO Graft implant for dialysis access
Treatment: HeRO Graft implant for dialysis access
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 10 May 2021